AFP and cancer: Daunorubicin itself destroys G-MDSC (granulocytic myeloid-derived suppressor cells) well, but once combined with AFP it also destroys M-MDSC (monocytic myeloid-derived suppressor cells), and these are more important in cancer immunosuppression than G-MDSCs [56,65].